{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:31:46Z","timestamp":1785411106241,"version":"3.56.0"},"posted":{"date-parts":[[2026,2,14]]},"group-title":"Bioengineering","reference-count":48,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"award":["R01EB024556"],"award-info":[{"award-number":["R01EB024556"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Nanomaterial-enabled delivery systems have transformed therapeutic strategies for treating inflammatory and degenerative diseases by enabling targeted delivery of small molecules and nucleic acids. However, the clinical translation of microRNA (miR) therapeutics remains limited by instability, enzymatic degradation, and inefficient intracellular delivery in biological environments. Here, we present the design and validation of a next-generation lipid nanoparticle (LNP) platform optimized for the stable and effective delivery of the anti-inflammatory microRNA miR-146a. This LNP system is produced using a scalable lipid injection-based formulation method and yields nanoparticles with uniform size distribution and exceptional physicochemical stability across a wide pH range (2.5-8) and in serum-containing conditions. The four-component lipid architecture enables high miR-146a loading efficiency, efficient endo\/lysosomal escape, and robust cellular internalization, resulting in effective tissue uptake and biodistribution both\n                  <jats:italic>in vitro<\/jats:italic>\n                  and\n                  <jats:italic>in vivo<\/jats:italic>\n                  . Importantly, LNP-mediated delivery of miR-146a exhibits excellent biocompatibility and potent anti-inflammatory activity in primary cells and animal models. Collectively, these results suggest this LNP-miR146a platform as a stable, efficient, and translatable approach for modulating inflammation and addressing biomaterial-associated inflammatory responses.\n                <\/jats:p>","DOI":"10.64898\/2026.02.13.705811","type":"posted-content","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T04:40:13Z","timestamp":1771130413000},"source":"Crossref","is-referenced-by-count":0,"title":["Endosome-escaping engineered LNP-miR146a with in vivo biodistribution to mitigate inflammation and foreign body giant cell formation"],"prefix":"10.64898","author":[{"given":"Mohammad I.","family":"Khan","sequence":"first","affiliation":[{"name":"University of Maryland, Department of Nutrition and Food Science, College Park, MD 20742"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karunakaran R.","family":"Sankaran","sequence":"additional","affiliation":[{"name":"University of Maryland, Department of Nutrition and Food Science, College Park, MD 20742"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaik O.","family":"Rahaman","sequence":"additional","affiliation":[{"name":"University of Maryland, Department of Nutrition and Food Science, College Park, MD 20742"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"6","key":"2026021707501795000_2026.02.13.705811v1.1","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1021\/acsnano.2c10042","article-title":"Cysteine-based redox-responsive nanoparticles for fibroblast-targeted drug delivery in the treatment of myocardial infarction","volume":"17","year":"2023","journal-title":"ACS nano"},{"key":"2026021707501795000_2026.02.13.705811v1.2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2020.12.016","article-title":"Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression","volume":"159","year":"2021","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"2026021707501795000_2026.02.13.705811v1.3","doi-asserted-by":"crossref","first-page":"128025","DOI":"10.1016\/j.cej.2020.128025","article-title":"To decipher the antibacterial mechanism and promotion of wound healing activity by hydrogels embedded with biogenic Ag@ ZnO core-shell nanocomposites","volume":"417","year":"2021","journal-title":"Chem. Eng. J"},{"issue":"1","key":"2026021707501795000_2026.02.13.705811v1.4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","year":"2024","journal-title":"Signal Transduct. Target. Ther"},{"key":"2026021707501795000_2026.02.13.705811v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2026021707501795000_2026.02.13.705811v1.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"issue":"11","key":"2026021707501795000_2026.02.13.705811v1.7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41578-025-00852-9","article-title":"Breaking the PEG barrier to boost mRNA-LNP therapeutics","volume":"10","year":"2025","journal-title":"Nat. Rev. Mater"},{"issue":"2","key":"2026021707501795000_2026.02.13.705811v1.8","doi-asserted-by":"crossref","first-page":"101463","DOI":"10.1016\/j.omtm.2025.101463","article-title":"Lipid Nanoparticles: Composition, Formulation and Application","volume":"33","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev"},{"key":"2026021707501795000_2026.02.13.705811v1.9","doi-asserted-by":"publisher","DOI":"10.7150\/thno.77259"},{"issue":"9","key":"2026021707501795000_2026.02.13.705811v1.10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12032-025-02939-3","article-title":"Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy","volume":"42","year":"2025","journal-title":"Med. Oncol"},{"key":"2026021707501795000_2026.02.13.705811v1.11","doi-asserted-by":"crossref","first-page":"114030","DOI":"10.1016\/j.jconrel.2025.114030","article-title":"Formulation methods for peptide-modified lipid nanoparticles","volume":"385","year":"2025","journal-title":"J. Control Release"},{"key":"2026021707501795000_2026.02.13.705811v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416"},{"issue":"7","key":"2026021707501795000_2026.02.13.705811v1.13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/pharmaceutics17070803","article-title":"Endo\/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy","volume":"17","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026021707501795000_2026.02.13.705811v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"2026021707501795000_2026.02.13.705811v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2008.04.004"},{"key":"2026021707501795000_2026.02.13.705811v1.16","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00037.2011"},{"key":"2026021707501795000_2026.02.13.705811v1.17","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-260323"},{"issue":"3","key":"2026021707501795000_2026.02.13.705811v1.18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/imm.12608","article-title":"Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation","volume":"148","year":"2016","journal-title":"Immunology"},{"key":"2026021707501795000_2026.02.13.705811v1.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-005-0066-3"},{"key":"2026021707501795000_2026.02.13.705811v1.20","doi-asserted-by":"crossref","first-page":"122855","DOI":"10.1016\/j.biomaterials.2024.122855","article-title":"Macrophage microRNA-146a is a central regulator of the foreign body response to biomaterial implants","volume":"314","year":"2025","journal-title":"Biomaterials"},{"key":"2026021707501795000_2026.02.13.705811v1.21","doi-asserted-by":"crossref","first-page":"529642","DOI":"10.1155\/2015\/529642","article-title":"MicroRNA dysregulation in cystic fibrosis","volume":"2015","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2026021707501795000_2026.02.13.705811v1.22","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2014-0101"},{"issue":"2","key":"2026021707501795000_2026.02.13.705811v1.23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1165\/rcmb.2017-0196TR","article-title":"Noncoding RNAs: new players in pulmonary medicine and sarcoidosis","volume":"58","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"2026021707501795000_2026.02.13.705811v1.24","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21257"},{"key":"2026021707501795000_2026.02.13.705811v1.25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01377"},{"key":"2026021707501795000_2026.02.13.705811v1.26","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-007-9013-8"},{"key":"2026021707501795000_2026.02.13.705811v1.27","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.4A1014-489R"},{"key":"2026021707501795000_2026.02.13.705811v1.28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.269035"},{"issue":"5","key":"2026021707501795000_2026.02.13.705811v1.29","first-page":"1041","article-title":"The role of miR-146a in modulating TRAF6-induced inflammation during lupus nephritis","volume":"21","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"key":"2026021707501795000_2026.02.13.705811v1.30","doi-asserted-by":"crossref","unstructured":"Saba, R. , Sorensen, D.L. , and Booth, S.A . MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response. Front. Immunol. 2014;5:578.","DOI":"10.3389\/fimmu.2014.00578"},{"key":"2026021707501795000_2026.02.13.705811v1.31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015010111"},{"issue":"1","key":"2026021707501795000_2026.02.13.705811v1.32","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1038\/s41598-019-49090-4","article-title":"miR-146a Deficiency Accelerates Hepatic Inflammation Without Influencing Diet-induced Obesity in Mice","volume":"9","year":"2019","journal-title":"Sci. Rep"},{"key":"2026021707501795000_2026.02.13.705811v1.33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002045"},{"key":"2026021707501795000_2026.02.13.705811v1.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007970"},{"key":"2026021707501795000_2026.02.13.705811v1.35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.07.016","article-title":"MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGF\u03b21 and lipopolysaccharide","volume":"39","year":"2017","journal-title":"Cell Signal"},{"key":"2026021707501795000_2026.02.13.705811v1.36","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310723"},{"key":"2026021707501795000_2026.02.13.705811v1.37","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1038\/srep16163","article-title":"MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a","volume":"5","year":"2015","journal-title":"Sci. Rep"},{"issue":"1","key":"2026021707501795000_2026.02.13.705811v1.38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41467-020-20449-w","article-title":"Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation","volume":"12","year":"2021","journal-title":"Nat. Commun"},{"issue":"25","key":"2026021707501795000_2026.02.13.705811v1.39","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1016\/j.biomaterials.2012.05.002","article-title":"2012. Lipid nanoparticles for hepatic delivery of small interfering RNA","volume":"33","year":"2012","journal-title":"Biomaterials"},{"key":"2026021707501795000_2026.02.13.705811v1.40","first-page":"337","volume-title":"Inflammation and cancer. Methods. Mol. Biol.","volume":"2691","year":"2023"},{"key":"2026021707501795000_2026.02.13.705811v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(02)00130-3"},{"issue":"6","key":"2026021707501795000_2026.02.13.705811v1.42","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.5c00014","article-title":"A Multimodal Therapeutic Strategy for Inflammatory Bowel Disease Using MicroRNA-146a Mimic Encapsulated in Lipid Nanoparticles","volume":"22","year":"2025","journal-title":"Mol. Pharm"},{"issue":"7","key":"2026021707501795000_2026.02.13.705811v1.43","doi-asserted-by":"crossref","first-page":"e18177","DOI":"10.1111\/jcmm.18177","article-title":"Avocado-derived extracellular vesicles loaded with ginkgetin and berberine prevent inflammation and macrophage foam cell formation","volume":"28","year":"2024","journal-title":"J. Cell. Mol. Med"},{"key":"2026021707501795000_2026.02.13.705811v1.44","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00187.2016"},{"issue":"707","key":"2026021707501795000_2026.02.13.705811v1.45","doi-asserted-by":"crossref","first-page":"eabd4077","DOI":"10.1126\/scisignal.abd4077","article-title":"Mechanosensing by TRPV4 mediates stiffness-induced foreign body response and giant cell formation","volume":"14","year":"2021","journal-title":"Sc. Signal"},{"key":"2026021707501795000_2026.02.13.705811v1.46","doi-asserted-by":"crossref","unstructured":"Mahanty, M. , Ou, W. , Zhu, X. , Bromberg, J.S. , He, X. , and Rahaman, S.O. A Novel Core-Shell Hydrogel 3D Model for Studying Macrophage Mechanosensing and Foreign Body Giant Cell Formation. Adv. Healthc. Mater. 2025:e01614.","DOI":"10.1002\/adhm.202501614"},{"key":"2026021707501795000_2026.02.13.705811v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(86)90215-2"},{"issue":"5","key":"2026021707501795000_2026.02.13.705811v1.48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00430-018-0564-z","article-title":"Biogenic Au@ ZnO core\u2013shell nanocomposites kill Staphylococcus aureus without provoking nuclear damage and cytotoxicity in mouse fibroblasts cells under hyperglycemic condition with enhanced wound healing proficiency","volume":"208","year":"2019","journal-title":"Med. Microbiol. Immunol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.02.13.705811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:50:28Z","timestamp":1771343428000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.02.13.705811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":48,"URL":"https:\/\/doi.org\/10.64898\/2026.02.13.705811","relation":{},"subject":[],"published":{"date-parts":[[2026,2,14]]},"subtype":"preprint"}}